Phase II study on the feasibility and efficacy of R-DHAP + HD-MTX, combined with intrathecal rituximab, followed by autologous stem cell transplantation in patients with a recurrent aggressive B-cell lymphoma with CNS localisation.
Latest Information Update: 25 Apr 2014
At a glance
- Drugs Rituximab (Primary) ; Cisplatin; Cytarabine; Dexamethasone; Methotrexate
- Indications B-cell lymphoma
- Focus Therapeutic Use
- Acronyms HOVON 80 NHL
- 30 Jan 2014 Status changed from recruiting to active, no longer recruiting as per Hovon.nl (www.Hovon.nl) record
- 14 May 2009 New trial record